Skip to main content

Table 4 Adverse effects of the study drugs

From: Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy

Adverse effects

Total N (%)

SP n (%)

DP n (%)

P value

Elevated maternal ALT level

3/116 (2.6)

2/52 (3.8)

1/64 (1.6)

0.586a

Fever

9/203 (4.4)

4/92 (4.3)

5/111 (4.5)

1.000a

Fatigue

1/203 (0.5)

0/92 (0.0)

1/111 (0.9)

1.000a

Headache

3/203 (1.5)

0/92 (0.0)

3/111 (2.7)

0.253a

Skin rash

2/203 (1.0)

0/92 (0.0)

2/111 (1.8)

0.502a

Nausea/Vomiting

4/203 (2.0)

4/92 (4.3)

0/111 (0.0)

0.041*a

Dizziness

2/203 (1.0)

2/92 (2.2)

0/111 (0.0)

0.204a

  1. ALT Alanine aminotransferase
  2. aFisher's exact test
  3. *Significant at P < 0.05